SynapDx Corporation Timeline | Circa 2010 – 2017 #NotAnAutisticAlly #AutisticHistory

About SynapDx Corp. “SynapDx is a private company providing laboratory diagnostics to physicians who suspect children of developmental disorders, with the initial goal of enabling earlier detection of autism spectrum disorders (ASDs). The company collaborates with ASD and gene expression experts at leading institutions, including Boston Children’s Hospital. SynapDx was founded 2010 and is based in …

Archived | Google-backed autism diagnostic firm SynapDx shuts down & More | Circa May 11, 2017 #AutisticHistory

Google-backed autism diagnostic firm SynapDx shuts down By Max Stendahl   –  Digital Editor, Boston Business Journal May 11, 2017, 1:25pm EDT “One of the risks of biotech companies is that sometimes you have a hypothesis, and nature just disagrees with you. That’s what happened here,” said GV’s Krishna Yeshwant. Read article here >> SynapDX is listed out of …

Archived | SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures | Circa July 22, 2013 #NotAnAutisticAlly #AutisticHistory

SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures Investment Propels Development of SynapDx’s Innovative Blood Test for the Early Diagnosis of AutismJuly 22, 2013 09:00 AM Eastern Daylight Time LEXINGTON, Mass.--(BUSINESS WIRE)--SynapDx Corporation, today announced it has secured a $15.4 million funding round, led by Google Ventures. Foundation Medical Partners also joined the financing as a …

Archived | Autism test maker secures $9m | Circa June 2, 2010

Screenshot of ”Autism test maker secures $9m” page on Boston.com. Autism test maker secures $9m Globe Staff / June 2, 2010 SynapDx Corp., a new Waltham company that aims to develop tests for the early detection of autism, yesterday announced the completion of a $9 million round of financing. Investing were Bain Capital Ventures, General Catalyst Partners, …

Archived | Featured Startup Pitch: Backed by some prominent investors, SynapDx is developing a test for significantly earlier Autism detection in children | Circa July 12, 2013 #NotAnAutisticAlly

Featured Startup Pitch: Backed by some prominent investors, SynapDx is developing a test for significantly earlier Autism detection in children July 12, 2013  StartUp BeatTM/ BRK Media, LLC.  Company: SynapDx Corporation Website: www.synapdx.com Video: http://www.vimeo.com/64564331 Headquarters: Lexington, Massachusetts Year Founded: 2010 Founders: Stanley Lapidus (President), Jeffrey Luber (VP, Corporate Development) Employees: 18 Investors: North Bridge Venture Partners, General Catalyst Partners, Laboratory Corporation of America, The …

Archived | SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference | Circa February 21, 2013 #NotAnAutisticAlly

synapdx-press-release-autism-investment-conference-participation-updated-final-2-21-13Download Image promoting 2014 Autism Investment Conference by Autism Speaks March 4-5 2014. FOR IMMEDIATE RELEASE SynapDx Corporation’s CEO Stanley Lapidus Presents at Inaugural Autism Investment Conference Discusses Diagnostic Issues at Event Hosted by Autism Speaks Lexington, MA – February 21, 2013 – SynapDx Corporation is joining a select group of autism-focused companies to present …

Archived | Lexington’s SynapDx gets $2m as it looks to develop new autism test & Press Releases | Circa February 21, 2013 #NotAnAutisticAlly AGRE Collection

SynapDx logo Lexington’s SynapDx gets $2m as it looks to develop new autism test By Chris Reidy | Boston.com SynapDx Corp., a Lexington firm developing diagnostics for the earlier detection of autism, said Thursday that it has gotten $2 million in funding from Laboratory Corporation of America Holdings, or LabCorp, a North Carolina-based company that specializes …